Seres Therapeutics: Q2 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported profit of $4.6 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had profit of 47 cents. Losses, adjusted for non-recurring gains, were $1.50 per share.

The drug developer posted revenue of $736,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB